Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.
about
Angiotensin peptides and nitric oxide in cardiovascular diseaseThe RGS2 (-391, C>G) genetic variation correlates to antihypertensive drug responses in Chinese patients with essential hypertensionOral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression.Antenatal betamethasone exposure alters renal responses to angiotensin-(1-7) in uninephrectomized adult male sheep.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionBeneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injuryNew insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin IIIndoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cellsShort-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.Lack of renoprotective effect of chronic intravenous angiotensin-(1-7) or angiotensin-(2-10) in a rat model of focal segmental glomerulosclerosis.Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney.Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and BradykininDiminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.The ACE2 gene: its potential as a functional candidate for cardiovascular disease.Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury.Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma.Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease.The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).Modulating role of Ang1-7 in control of blood pressure and renal function in AngII-infused hypertensive rats.Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15.
P2860
Q27022788-24681F0C-FCEE-44A5-B75B-16FFFF134D97Q28545858-2E3660EB-6239-4BAB-ACB3-347C41F07ABBQ30600509-C4629875-3DF6-4C93-9CC9-0ADDE4445AACQ31053453-05D9E8EA-FA36-419D-B465-49E40AB56F6FQ33609249-43ED3AE3-FE7F-45EA-96E0-8544F79B7B85Q33795353-B23B58B0-B5CC-41C2-8FDF-DB8769DAA97AQ34770468-7FFF5D15-0BA9-4706-9B5E-C34F0CED3F7EQ34866649-9FA7A2A2-0FDA-49E5-9D81-882398EAE8D2Q35109349-7AAA73B5-E3CF-4815-9BA2-55C851A97DCAQ35116379-CA6A4217-1BF1-463B-BC8A-607BBCFF39B2Q35192530-87DDA154-BC49-434E-996D-5144BC985736Q35358295-035AC7A6-1DEA-4890-8D4F-D704D552D750Q35726197-4EF8DF15-D1E4-4A9E-8484-B1C970B74996Q35810568-C0554030-7F41-4290-9870-66D8490D3A8AQ35838004-F4B90738-1541-4828-A02F-C00117713A37Q36084248-0D28F1F8-DF39-413F-BED2-1FE197ED3D55Q36116045-D9B761FE-6D4C-4A62-8B28-DE85EC41423EQ36278567-DB2B8FCD-0A19-4376-96C9-3D531E6AA479Q36929414-46457D0B-8424-4B56-A4FF-B98787D454A2Q37938867-872B6591-7940-4AA7-A58F-32B0956DD8B7Q38046618-9AB90B89-BF41-444A-9E5D-CADE1C9F0D31Q38083745-2401DCF2-28AF-4C9A-B04F-5922FAC30FF1Q38207841-50F7A538-B11A-44DF-A7AE-C6FF87EC96FBQ38832985-3E118F99-51A7-441D-9041-2D430F810618Q39599579-EBA90423-AD90-442A-9FED-4E9F94A4DA2BQ43476643-798215A0-EE50-4203-8240-9E34322C342BQ44428408-D4C7B110-8140-49E2-82E6-32AA94344A00Q46924901-2B1D355F-4E3B-477E-9AC5-750964D12765Q47851502-387458F3-6C47-40B2-9F2A-88D9191B6618Q48516752-2E16B2DE-2E3B-453F-AD63-CC2EC296B533Q55467665-649B03A6-C132-49F5-8D24-0D8619EEF704
P2860
Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Angiotensin-(1-7) infusion is ...... ats with subtotal nephrectomy.
@ast
Angiotensin-(1-7) infusion is ...... ats with subtotal nephrectomy.
@en
type
label
Angiotensin-(1-7) infusion is ...... ats with subtotal nephrectomy.
@ast
Angiotensin-(1-7) infusion is ...... ats with subtotal nephrectomy.
@en
prefLabel
Angiotensin-(1-7) infusion is ...... ats with subtotal nephrectomy.
@ast
Angiotensin-(1-7) infusion is ...... ats with subtotal nephrectomy.
@en
P2093
P2860
P356
P1433
P1476
Angiotensin-(1-7) infusion is ...... rats with subtotal nephrectomy
@en
P2093
Elena Velkoska
Karen Griggs
Louise M Burrell
Rachael G Dean
P2860
P304
P356
10.1042/CS20100280
P407
P577
2011-04-01T00:00:00Z